PT - JOURNAL ARTICLE AU - Gonzaga-Jauregui, Claudia AU - Kurolap, Alina AU - Walsh, Lauren AU - Staples, Jeffrey AU - Van Hout, Cristopher AU - Oetjens, Matthew AU - Liu, Daren AU - , AU - Samaco, Rodney AU - Weiss, Karin AU - Feldman, Hagit Baris AU - Martin, Christa L. TI - Genomic analyses in a large clinical cohort reveal high prevalence of <em>MECP2</em> variants associated with neuropsychiatric phenotypes in adulthood AID - 10.1101/2021.05.31.21257498 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.31.21257498 4099 - http://medrxiv.org/content/early/2021/07/28/2021.05.31.21257498.short 4100 - http://medrxiv.org/content/early/2021/07/28/2021.05.31.21257498.full AB - This manuscript has been withdrawn as it was submitted without full consent of all the authors.Competing Interest StatementJS, DL, are full-time employees of the Regeneron Genetics Center and receive salary and stock options as part of compensation. All other authors have no conflict of interest to disclose.Funding StatementNo funding sources to disclose.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Proband 1 and her parents consented for research genomic studies through an institutional research study approved by the Rambam Helsinki Committee, study number 0038-14-RMB. DiscovEHR participants were consented in accordance with the Geisinger Health System (GHS) Institutional Review Board approved protocol, study number 2006-0258.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yes